Cargando…
Urine TERT promoter mutations-based tumor DNA detection in patients with bladder cancer: A pilot study
Telomerase reverse transcriptase (TERT) promoter mutations are the most frequent genetic events in bladder cancer (BC). The aim of the present pilot study was to evaluate the diagnostic potential of urine TERT promoter mutations-based liquid biopsy in patients with an ongoing oncological process, as...
Autores principales: | Jain, Mark, Kamalov, David, Tivtikyan, Alexander, Balatsky, Alexander, Samokhodskaya, Larisa, Okhobotov, Dmitry, Kozlova, Polina, Pisarev, Eduard, Zvereva, Maria, Kamalov, Armais |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548999/ https://www.ncbi.nlm.nih.gov/pubmed/34712485 http://dx.doi.org/10.3892/mco.2021.2415 |
Ejemplares similares
-
Development of a Sensitive Digital Droplet PCR Screening Assay for the Detection of GPR126 Non-Coding Mutations in Bladder Cancer Urine Liquid Biopsies
por: Jain, Mark, et al.
Publicado: (2023) -
Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer
por: Zvereva, Maria, et al.
Publicado: (2020) -
Tissue ACE phenotyping in prostate cancer
por: Danilov, Sergei M., et al.
Publicado: (2019) -
Prostatic Artery Embolization for Benign Prostatic Hyperplasia
Treatment: A Russian Multicenter Study in More Than 1,000 Treated
Patients
por: Kamalov, Armais, et al.
Publicado: (2020) -
Blood ACE Phenotyping for Personalized Medicine: Revelation of Patients with Conformationally Altered ACE
por: Danilov, Sergei M., et al.
Publicado: (2023)